Guanidine Hydrochloride → HCID 178432059, 화합물
반응식
C([O:4][CH:5]1[C:11]2=[N:12][C:13]([CH3:21])=[C:14]([C:16](OCC)=[O:17])[CH:15]=[C:10]2[CH2:9][CH2:8][CH2:7][CH2:6]1)(=O)C.Cl.[NH2:23][C:24]([NH2:26])=[NH:25]>>[OH:4][CH:5]1[C:11]2=[N:12][C:13]([CH3:21])=[C:14]([C:16]([NH:25][C:24]([NH2:26])=[NH:23])=[O:17])[CH:15]=[C:10]2[CH2:9][CH2:8][CH2:7][CH2:6]1참가 물질
3
실험 절차
When the method of Inventive Example 1 was repeated using ethyl 9-acetoxy-2-methyl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carboxylate (450.0 mg, 1.55 mmol) and guanidine hydrochloride (2.67 g, 28.0 mmol), hydrolysis of the acetoxy group occurred at the same time, and the title compound (237.8 mg, 58.9%) was obtained as white powder.
출처 및 근거
- ORD 기록
- ord-89501d3bebf44fe6be6637960f55efac
- 출처 데이터셋
- uspto-grants-2001_07
- 특허 번호
- US06258829B1
반응 노트
불러오는 중…